{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:35:40Z","timestamp":1780673740918,"version":"3.54.1"},"reference-count":40,"publisher":"Spandidos Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2024.12573","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T12:12:17Z","timestamp":1715775137000},"source":"Crossref","is-referenced-by-count":5,"title":["Serum miR\u201129 is increased in mice with early liver fibrosis"],"prefix":"10.3892","volume":"28","author":[{"given":"Kana","family":"Matsumoto","sequence":"first","affiliation":[{"name":"Department of Bioscience and Laboratory Medicine, Graduate School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036\u20118564, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Ohsugi","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036\u20118564, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisa","family":"Tayama","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036\u20118564, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momone","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036\u20118564, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036\u20118564, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuho","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036\u20118564, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Bioscience and Laboratory Medicine, Graduate School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036\u20118564, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"key":"key20240618110508_b1-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/jgh.12271","article-title":"Characteristics and diagnosis of NAFLD\/NASH","volume":"28","author":"Hashimoto","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"key20240618110508_b2-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"key20240618110508_b3-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/hep4.1479","article-title":"Pathogenesis of nonalcoholic steatohepatitis: An overview","volume":"4","author":"Parthasarathy","year":"2020","journal-title":"Hepatol Commun"},{"key":"key20240618110508_b4-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.2147\/DDDT.S315724","article-title":"Non-alcoholic steatohepatitis (NASH)-A review of a crowded clinical landscape, driven by a complex disease","volume":"15","author":"Fraile","year":"2021","journal-title":"Drug Des Dev Ther"},{"key":"key20240618110508_b5-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"key20240618110508_b6-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J Hepatol"},{"key":"key20240618110508_b7-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update","volume":"75","year":"2021","journal-title":"J Hepatol"},{"key":"key20240618110508_b8-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling variability of liver biopsy in nonalcoholic fatty liver disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"key":"key20240618110508_b9-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/hep.21346","article-title":"Correlation of paired liver biopsies in morbidly obese patients with suspected nonalcoholic fatty liver disease","volume":"44","author":"Merriman","year":"2006","journal-title":"Hepatology"},{"issue":"101167","key":"key20240618110508_b10-ETM-28-1-12573","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2021.101167","article-title":"Imaging biomarkers of NAFLD, NASH, and fibrosis","volume":"50","author":"Ajmera","year":"2021","journal-title":"Mol Metab"},{"key":"key20240618110508_b11-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"E53","DOI":"10.1111\/hepr.12456","article-title":"Serum alanine aminotransferase predicts the histological course of non-alcoholic steatohepatitis in Japanese patients","volume":"45","author":"Seko","year":"2015","journal-title":"Hepatol Res"},{"key":"key20240618110508_b12-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"817","DOI":"10.17179\/excli2016-800","article-title":"The past and present of serum aminotransferases and the future of liver injury biomarkers","volume":"15","author":"McGill","year":"2016","journal-title":"Excli J"},{"key":"key20240618110508_b13-ETM-28-1-12573","first-page":"477","article-title":"APRI: A simple bedside marker for advanced fibrosis that can avoid liver biopsy in patients with NAFLD\/NASH","volume":"101","author":"Kruger","year":"2011","journal-title":"S Afr Med J"},{"key":"key20240618110508_b14-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","article-title":"Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease","volume":"7","author":"Shah","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20240618110508_b15-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"key20240618110508_b16-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/hep.21223","article-title":"In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease","volume":"44","author":"Wieckowska","year":"2006","journal-title":"Hepatology"},{"key":"key20240618110508_b17-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s10620-015-3916-1","article-title":"Poor inter-test reliability between CK18 kits as a biomarker of NASH","volume":"61","author":"Pimentel","year":"2016","journal-title":"Dig Dis Sci"},{"key":"key20240618110508_b18-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jhep.2013.07.042","article-title":"Limited value of plasma cytokeratin-18 as a biomarker for NASH and fibrosis in patients with non-alcoholic fatty liver disease","volume":"60","author":"Cusi","year":"2014","journal-title":"J Hepatol"},{"key":"key20240618110508_b19-ETM-28-1-12573","first-page":"236","article-title":"MicroRNAs: A newly described class of encoded molecules that play a role in health and disease","volume":"14","author":"Felekkis","year":"2010","journal-title":"Hippokratia"},{"key":"key20240618110508_b20-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: Biology, functions, therapeutics, and analysis methods","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J Cell Physiol"},{"issue":"2028","key":"key20240618110508_b21-ETM-28-1-12573","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17122028","article-title":"Exosomes as miRNA carriers: Formation-function-future","volume":"17","author":"Yu","year":"2016","journal-title":"Int J Mol Sci"},{"key":"key20240618110508_b22-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"key20240618110508_b23-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/iep.12008","article-title":"An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis","volume":"94","author":"Matsumoto","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"key20240618110508_b24-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.2174\/1389557523666230328125031","article-title":"The role of MiR-29 in the mechanism of fibrosis","volume":"23","author":"Wang","year":"2023","journal-title":"Mini Rev Med Chem"},{"issue":"243","key":"key20240618110508_b25-ETM-28-1-12573","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci13020243","article-title":"Potential regulation of miRNA-29 and miRNA-9 by estrogens in neurodegenerative disorders: An insightful perspective","volume":"13","author":"Ebada","year":"2023","journal-title":"Brain Sci"},{"issue":"123280","key":"key20240618110508_b26-ETM-28-1-12573","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.123280","article-title":"Overview of the miR-29 family members' function in breast cancer","volume":"230","author":"Amirian","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"key20240618110508_b27-ETM-28-1-12573","first-page":"5592","article-title":"TGF-\u03b21\/Smad3 signaling promotes collagen synthesis in pulmonary artery smooth muscle by down-regulating miR-29b","volume":"11","author":"Wang","year":"2018","journal-title":"Int J Clin Exp Pathol"},{"issue":"173507","key":"key20240618110508_b28-ETM-28-1-12573","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173507","article-title":"MicroRNA interplay between hepatic stellate cell quiescence and activation","volume":"885","author":"Ezhilarasan","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"key20240618110508_b29-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1038\/mt.2016.127","article-title":"MiR-29a assists in preventing the activation of human stellate cells and promotes recovery from liver fibrosis in mice","volume":"24","author":"Matsumoto","year":"2016","journal-title":"Mol Ther"},{"issue":"1298","key":"key20240618110508_b30-ETM-28-1-12573","doi-asserted-by":"publisher","DOI":"10.3390\/cells8101298","article-title":"MicroRNA-29a suppresses CD36 to ameliorate high fat diet-induced steatohepatitis and liver fibrosis in mice","volume":"8","author":"Lin","year":"2019","journal-title":"Cells"},{"issue":"10606","key":"key20240618110508_b31-ETM-28-1-12573","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-28854-4","article-title":"Non-invasive prediction of NAFLD severity: A comprehensive, independent validation of previously postulated serum microRNA biomarkers","volume":"8","author":"L\u00f3pez-Riera","year":"2018","journal-title":"Sci Rep"},{"issue":"14639","key":"key20240618110508_b32-ETM-28-1-12573","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-94115-6","article-title":"Circulating miRNA is a useful diagnostic biomarker for nonalcoholic steatohepatitis in nonalcoholic fatty liver disease","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"issue":"188","key":"key20240618110508_b33-ETM-28-1-12573","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4575-3","article-title":"A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis","volume":"19","author":"Liu","year":"2018","journal-title":"BMC Genomics"},{"issue":"8822859","key":"key20240618110508_b34-ETM-28-1-12573","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8822859","article-title":"Noncoding RNAs in nonalcoholic fatty liver disease: Potential diagnosis and prognosis biomarkers","volume":"2020","author":"Khalifa","year":"2020","journal-title":"Dis Markers"},{"key":"key20240618110508_b35-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/2211536607666180531093302","article-title":"Serum miR-29a and miR-122 as potential biomarkers for non-alcoholic fatty liver disease (NAFLD)","volume":"7","author":"Jampoka","year":"2018","journal-title":"Microrna"},{"issue":"113","key":"key20240618110508_b36-ETM-28-1-12573","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-024-05797-3","article-title":"Circular RNA cVIM promotes hepatic stellate cell activation in liver fibrosis via miR-122-5p\/miR-9-5p-mediated TGF-\u03b2 signaling cascade","volume":"7","author":"Zhou","year":"2024","journal-title":"Commun Biol"},{"key":"key20240618110508_b37-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.omtn.2018.04.005","article-title":"MiR-24 and miR-122 negatively regulate the transforming growth factor-\u03b2\/Smad signaling pathway in skeletal muscle fibrosis","volume":"11","author":"Sun","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"key20240618110508_b38-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/cmi.2011.53","article-title":"Liver fibrosis: Mechanisms of immune-mediated liver injury","volume":"9","author":"Xu","year":"2012","journal-title":"Cell Mol Immunol"},{"key":"key20240618110508_b39-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.bpg.2014.07.008","article-title":"Non-alcoholic fatty liver disease, obesity and the metabolic syndrome","volume":"28","author":"Dietrich","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"key20240618110508_b40-ETM-28-1-12573","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T08:10:32Z","timestamp":1718698232000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2024.12573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,5,15]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2024.12573","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"article-number":"285"}}